An investigational virtual reality oculokinetic perimetry (VR-OKP) platform is showing promise for overcoming many of the limitations that accompany standard perimetry.
Glaucoma genetics research can define the molecular basis of glaucoma and targets for developing curative or even preventive therapies, and it also pro-vides a basis for diagnostic and screening tests.
While articles and discussions on minimally invasive glaucoma surgery (MIGS) seem to be everywhere (for better or worse), “trabeculectomy will survive,” said Kuldev Singh, MD, because of the aging population, the ease of postoperative tit
Careful patient selection and education is always important when deciding to implant a premium intraocular lens (IOL) after cataract removal, but there may be additional structural and functional considerations for patients with comorbid
While MIGS has forever changed the surgical management of glaucoma, the space continues to evolve.
If you find yourself waffling back and forth on private equity, Ruth D. Williams, MD, has some guidance tips to make the decision easier.
Janey L. Wiggs, MD, PhD, shares the key points from her presentation.
Ellie Chabi, MD, Therapeutic Area Head for Glaucoma & Neuroprotection and Lead for Artificial Intelligence Programs within Global Biomedical Science for Santen, provides an update on its glaucoma pipeline.
Joel S. Schuman, MD, FACS, shares what's in store for regenerative ophthalmology at the annual Glaucoma 360 2019 meeting.
Robert L. Stamper, MD, discusses the current state of OCT angiography, and what remains on the horizon for glaucoma care.